Medication info
Glucophage XR Extended-Release Tablet (Metformin Hydrochloride)

Glucophage XR Extended-Release Tablet (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Merck
Appearance
White to off-white, biconvex, round extended-release tablet
Packaging
60 tablets (15 tablets/PTP packaging X 4)
Approval status
Active

MFDS item code 200511029 · Approved 2005.07.15 · Insurance code 661700110

Summary

Main use
Treatment of type 2 diabetes mellitus in adults
Who takes it
Adults
Adult dose
The dose should be determined individually based on the drug's efficacy and tolerability, and should not exceed the recommended maximum daily dose. - The usual initial dose is metformin hydrochloride extended-release tablets 500mg once daily with the evening meal. - Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase by 500mg each week; up to a maximum of 2000mg per day may be taken with the evening meal. If blood glucose is not controlled with a maximum of 2000mg once daily, consider administering 1000mg twice daily, with both doses taken with meals. - For patients already being treated with metformin tablets, the initial dose of this formulation is the same as the daily dose of immediate-release metformin tablets. Switching to this formulation is not recommended for patients taking more than 2000mg per day of immediate-release metformin tablets. - During treatment initiation and dose adjustment, fasting blood glucose should be measured to assess the response to this medicine and identify the minimum effective dose. Glycated hemoglobin levels should be measured approximately every 3 months. - The goal of treatment with this medicine, whether given as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73m2, this medicine must be discontinued immediately.

Ingredients

Importer
Merck

Efficacy & effects

Treatment of type 2 diabetes mellitus in adults

  • Type 2 diabetes with insufficient blood sugar control
View approved original text

This medication is used in patients with type 2 diabetes whose blood sugar levels are difficult to control with diet and exercise alone, especially in those who are overweight. It can be used alone or in combination with other oral hypoglycemic agents or insulin for effective blood sugar management. It improves blood sugar control in patients and assists in diabetes treatment.

How to take

Adult dose

The dose should be determined individually based on the drug's efficacy and tolerability, and should not exceed the recommended maximum daily dose. - The usual initial dose is metformin hydrochloride extended-release tablets 500mg once daily with the evening meal. - Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase by 500mg each week; up to a maximum of 2000mg per day may be taken with the evening meal. If blood glucose is not controlled with a maximum of 2000mg once daily, consider administering 1000mg twice daily, with both doses taken with meals. - For patients already being treated with metformin tablets, the initial dose of this formulation is the same as the daily dose of immediate-release metformin tablets. Switching to this formulation is not recommended for patients taking more than 2000mg per day of immediate-release metformin tablets. - During treatment initiation and dose adjustment, fasting blood glucose should be measured to assess the response to this medicine and identify the minimum effective dose. Glycated hemoglobin levels should be measured approximately every 3 months. - The goal of treatment with this medicine, whether given as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73m2, this medicine must be discontinued immediately.

Precautions

This medication can rarely cause a dangerous condition known as severe lactic acidosis, so immediate consultation with medical professionals is necessary if symptoms appear. Care should be taken to be aware of the risk of hypoglycemia when using this medication alongside other diabetes medications. Patients with moderate to severe renal impairment or those with acute illnesses such as severe infection or heart failure should not use this medication. Especially when undergoing tests using radiologic iodine contrast agents, the use of this medication should be stopped, and renal function checked before resuming. This medication is not used in patients with hypersensitivity to it or in those with type 1 diabetes. In cases of severe infection or major surgery, treatment should be temporarily suspended and resumed once the condition stabilizes. Patients with poor nutritional status or impaired liver function, as well as those with excessive alcohol consumption, also require caution. Gastrointestinal disturbances may commonly occur with this medication; thus, starting the dose slowly and taking it with food is recommended. Regular blood tests are recommended due to the potential for vitamin B12 deficiency. This medication should be swallowed whole without chewing or crushing, and the tablet coating may appear in the stool, which is normal. During pregnancy, fetal growth should be closely monitored, and during breastfeeding, it is advisable to avoid using this medication. Elderly patients may be at risk for reduced kidney function, so dosage adjustments and regular kidney function tests are required. In case of overdose, blood dialysis may be necessary, and immediate medical attention should be sought. Avoid alcohol consumption while taking this medication and be mindful of interactions with other medications, especially those that may affect kidney function. Regular checks of blood sugar levels and prompt reporting of unusual symptoms to a physician are important.

Side effects

  • lactic acidosis
  • severe hypoglycemia
  • vitamin B12 deficiency
  • taste impairment
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • erythema
Show 3 more
  • itching
  • urticaria
  • rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a closed container due to its sensitivity to air and moisture. It is recommended to maintain storage temperatures between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White to off-white, biconvex, round extended-release tablet

Package unit

60 tablets (15 tablets/PTP packaging X 4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.